UBS Group’s BioVie Inc Warrant BIVIW Stock Holding History

UBS Group’s Portfolio BIVIW Stock Details BIVIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$70.5K	Buy	+223,220	New	+$76.3K	﹤0.01%	7380
2026 Q1	–	Sell	-425	Closed	-$115	–	11679
2025 Q4	$115	Sell	425 -575	-58%	-$188	﹤0.01%	10169
2025 Q3	$412	Buy	+1,000	New	+$407	﹤0.01%	9688

Other funds holding BIVIW

WAM

Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $43.4M AUM 20.78% 1-Year Est. Return

UBS Group's BIVIW Position: Q3 2026 in Review

UBS Group opened a new position in BioVie Inc Warrant (BIVIW) in Q3 2026: 223,220 shares worth $70.5K. The stake represents ﹤0.01% of the portfolio and ranks #7380 among its holdings. This is a return to the name: UBS Group previously reported a position in BIVIW as recently as Q4 2025.

UBS Group first reported a position in BIVIW in Q3 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold BIVIW as of Q3 2026.

UBS Group held 223,220 shares of BioVie Inc Warrant worth $70.5K as of Q3 2026.
BioVie Inc Warrant was a new UBS Group position in Q3 2026.
BioVie Inc Warrant made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #7380 holding.
UBS Group first reported a position in BioVie Inc Warrant in Q3 2025 and has held it in 3 quarters since.
4 funds tracked by Wall St. Rank held BioVie Inc Warrant as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.